Trials / Completed
CompletedNCT06005376
Development of a Celiac Safe Food Additive
Development of a Celiac Safe Food Additive: An Intervention Study in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Chalmers University of Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial was to investigate if intestinal deamidation of gliadin from wheat bread could be hindered by adding a E304i/zinc additive. The study was a randomized double-blind 4-week crossover intervention in 20 healthy volunteers in which the participants ingested 2 bread rolls a day during the intervention weeks. The question it aimed to answer was if there was a difference in blood levels of deamidated gliadin peptides after ingestion of the reference wheat bread compared with the wheat bread containing the food additive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Breakfast rolls consisting of wheat flour with and without a E304i/zinc additive | The participants were provided with two Breakfast rolls (a 40 g) a day during the intervention week. In addition, they were provided with gluten-free foods during the whole trial. |
Timeline
- Start date
- 2020-07-29
- Primary completion
- 2020-11-02
- Completion
- 2020-11-02
- First posted
- 2023-08-22
- Last updated
- 2023-08-22
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06005376. Inclusion in this directory is not an endorsement.